08:58 AM EDT, 07/10/2026 (MT Newswires) -- Healthcare stocks were advancing premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.4% higher and the iShares Biotechnology ETF (IBB) up 0.5%.

Mesoblast (MESO) shares were up more than 4% after the company said sales of its steroid-refractory acute graft-versus-host disease treatment, Ryoncil, totaled $36 million in fiscal Q4.